What should patients know about CAR T-cell therapy?

Michael Williams, MD, from the Emily Couric Clinical Cancer Center, Charlottesville, VA, discusses CAR T-cell therapy at the International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2017, held in Vancouver, BC, Canada. CAR T-cell treatment is very well known, however, it may not be appropriate in all scenarios. This treatment is still investigational, with the first therapy being approved by the FDA later this year. Despite this, there is still a large number of treatment options available for patients with mantle cell lymphoma.

Share this video